Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas

NCT04730583 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04730583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04730583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Completed
Start date
June 2, 2021
Completion date
April 19, 2024
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous neurofibroma